Table 3 Treatment-related adverse events (TRAEs) identified by investigators
Grade 1 | Grade 2 | Grade 3 | Grade 4 | |||||
|---|---|---|---|---|---|---|---|---|
No | % | No | % | No | % | No | % | |
All patients with an event | 27 | 96.4 | 18 | 64.2 | 10 | 35.7 | 2 | 7.1 |
Anorexia | 9 | 32.1 | 2 | 7.1 | 1 | 3.6 | 0 | 0.0 |
Nausea | 7 | 25.0 | 1 | 3.6 | 0 | 0.0 | 0 | 0.0 |
Vomiting | 1 | 3.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Fatigue | 3 | 10.7 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Constipation | 1 | 3.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Diarrhea | 0 | 0.0 | 1 | 3.6 | 0 | 0.0 | 0 | 0.0 |
Rash | 2 | 7.1 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Dizziness | 1 | 3.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Alopecia | 6 | 21.4 | 9 | 32.1 | 0 | 0.0 | 0 | 0.0 |
Oral mucositis | 0 | 0.0 | 1 | 3.6 | 0 | 0.0 | 0 | 0.0 |
Dermatitis radiation | 1 | 3.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
White blood cell decreased | 5 | 17.9 | 5 | 17.9 | 5 | 17.9 | 0 | 0.0 |
Neutropenia | 7 | 25.0 | 6 | 21.4 | 6 | 21.4 | 2 | 7.1 |
Creatinine increased | 5 | 17.9 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Anemia | 14 | 50.0 | 2 | 7.1 | 0 | 0.0 | 0 | 0.0 |
Alanine aminotransferase increased | 1 | 3.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Aspartate aminotransferase increased | 1 | 3.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Blood bilirubin increased | 1 | 3.6 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Hyperuricemia | 6 | 21.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
Hyperglycemia | 6 | 21.4 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 |
